Navigation Links
2 Hopkins scientists awarded European honorary doctorates
Date:4/16/2010

Two genetics researchers from the Johns Hopkins University School of Medicine have been awarded prestigious honorary Doctor of Medicine degrees by European scientific institutions.

Andrew P. Feinberg, M.D., M.P.H., King Fahd Professor of Molecular Medicine and director of the Center for Epigenetics, will receive the honorary doctorate from the Karolinska Institutet of Sweden during a ceremony in the Stockholm City Hall on May 7.

Craig Montell, Ph.D, professor of biological chemistry and member of the Center for Sensory Biology at Johns Hopkins, received his degree from the Katholieke Universiteit Leuven in Belgium on Friday, March 26.

For more than a quarter century, Feinberg has been investigating how genetic factors outside human nuclear DNA, or "epigenetic" phenomena, are related to human disease, having done the first experiments on the epigenetics of cancer in the early 1980s. More recently, he has been leading a group in the study of the epigenetics of human complex traits with a Center of Excellence in Genome Sciences (CEGS) award from the Genome Research Institute of the NIH.

In addition to directing the Center for Epigenetics at Hopkins, Feinberg has been an adjunct professor at Karolinska Institutet and contributed to its formation of an epigenetic profiling platform at its Center for Molecular Medicine. The Board of Research of Karolinska stated, "Professor Feinberg's work saves lives and he personally encourages other researchers to push the boundaries of knowledge in biology and medicine."

Craig Montell, of the Center for Sensory Biology, joined the Johns Hopkins faculty in 1988 and a year later, published a seminal paper on the cloning of the gene encoding the founding TRP channel in the fruit fly. In 1995 Montell reported the identification of human TRP proteins. The various members of the TRP family of proteins have transformed our understanding about how animals, ranging from insects to humans, detect a broad array of sensory stimuli.

Recently, the Montell group revealed the cellular mechanism underlying an early childhood neurodegenerative disease, mucolipidosis type IV, providing a novel strategy for treating this disease.

"The research community at Johns Hopkins is proud that both Andy and Craig have received such honors," says Stephen Desiderio, M.D., Ph.D., director of the Johns Hopkins Institute for Basic Biomedical Sciences. "Each has contributed significantly over the years to his respective field as well as to the scientific enterprise at Hopkins and this recognition of their work is much deserved."


'/>"/>

Contact: Maryalice Yakutchik
myakutc1@jhmi.edu
443-287-2251
Johns Hopkins Medical Institutions
Source:Eurekalert  

Related biology news :

1. Vaginal reconstruction not needed for most inter-sex females, Hopkins study shows
2. Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit
3. Johns Hopkins scientists discover what drives the development of a fatal form of malaria
4. Hopkins researchers piece together gene network linked to schizophrenia
5. Johns Hopkins researchers detect sweet cacophony while listening to cellular cross-talk
6. Johns Hopkins scientists pull proteins tail to curtail cancer
7. Hopkins scientists ID 10 genes associated with a risk factor for sudden cardiac death
8. Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant awarded to Johns Hopkins Early Career investigator
9. Johns Hopkins scientists discover a controller of brain circuitry
10. Hopkins researchers put proteins right where they want them
11. UK scientists working to help cut ID theft
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
2 Hopkins scientists awarded European honorary doctorates
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a leading ... the release of its patent-pending calibration device. With this ... perform calibrations, securely upload data logs and process repairs ... customer. "Fighting drunk driving through the application ... public at large, but also for the customer who ...
(Date:1/6/2017)... Jan. 6, 2017  Privately-held CalciMedica, Inc., announced ... healthy volunteers of a novel calcium release-activated calcium ... pancreatitis. Acute pancreatitis, sudden painful ... disorder, but can be very serious.  In severe cases ... where extended hospital stays, time in the ICU ...
(Date:1/6/2017)... 5, 2017  Delta ID Inc., a leader in ... for automotive at CES® 2017. Delta ID has collaborated ... demonstrate the use of iris scanning as a secure, ... driver in a car, and as a way to ... Delta ID and Gentex will demonstrate (booth ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)("Interpace" ... useful molecular diagnostic tests and pathology services, today ... purchase agreement with three  institutional investors to purchase ... in a registered direct offering.  In a concurrent ... to the same investors warrants to purchase 855,000 ...
(Date:1/21/2017)... Jan. 20, 2017 Aratana Therapeutics, Inc. (NASDAQ: ... on the licensing, development and commercialization of innovative biopharmaceutical ... Best Company in North America ... award based on the FDA approval of three ... ENTYCE ® (capromorelin oral solution) and NOCITA ® ...
(Date:1/20/2017)... , ... January 20, 2017 , ... The two newest ... treatment options for patients. Vironika, a spin out from The Wistar Institute, and Sanguis, ... lab space at 3624 Market Street. , Vironika is developing a treatment for ...
(Date:1/20/2017)... , Jan. 20, 2017 Ginkgo ... of Gen9, a pioneer in the synthesis and ... unique expertise in assembling pathway-length synthetic DNA into ... and capacity in the construction of new organism ... industries. "Gen9 was founded to significantly ...
Breaking Biology Technology: